These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24885776)

  • 1. Inhibition of hepatitis C virus by an M1GS ribozyme derived from the catalytic RNA subunit of Escherichia coli RNase P.
    Mao X; Li X; Mao X; Huang Z; Zhang C; Zhang W; Wu J; Li G
    Virol J; 2014 May; 11():86. PubMed ID: 24885776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of the in vitro antiviral activity of an engineered M1GS ribozyme that targets to the core gene of hepatitis C virus].
    Zhang W; Li X; Luo G; Huang Z; Liu Y
    Wei Sheng Wu Xue Bao; 2013 Aug; 53(8):875-81. PubMed ID: 24341280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction of an engineered M1GS-HCV/C141 ribozyme and determination of its antiviral activity in vitro].
    Li X; Zhang W; Huang Z; Zhang C; Luo G
    Sheng Wu Gong Cheng Xue Bao; 2013 Dec; 29(12):1786-95. PubMed ID: 24660626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.
    Trang P; Lee M; Nepomuceno E; Kim J; Zhu H; Liu F
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5812-7. PubMed ID: 10811889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing RNase P ribozymes for gene-targeting and antiviral therapy.
    Trang P; Kim K; Liu F
    Cell Microbiol; 2004 Jun; 6(6):499-508. PubMed ID: 15104592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of RNase P Ribozyme Regions in Proximity with a Human RNase P Subunit Protein Using Fe(II)-EDTA Cleavage and Nuclease Footprint Analyses.
    Trang P; Smith A; Liu F
    Methods Mol Biol; 2023; 2666():55-67. PubMed ID: 37166656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic M1GS RNA as an antiviral agent in animals.
    Bai Y; Rider PJ; Liu F
    Methods Mol Biol; 2010; 629():339-53. PubMed ID: 20387160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1.
    Trang P; Kilani A; Kim J; Liu F
    J Mol Biol; 2000 Aug; 301(4):817-26. PubMed ID: 10966788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of an effective m1 GS ribozyme targeting HCMV UL97 mRNA segment in vitro.
    Zhang WJ; Li HJ; Li YQ; He HK; Tang DS; Zhang X; Zhou TH
    Yi Chuan Xue Bao; 2005 Nov; 32(11):1205-12. PubMed ID: 16318287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular expression of engineered RNase P ribozymes effectively blocks gene expression and replication of human cytomegalovirus.
    Kim K; Umamoto S; Trang P; Hai R; Liu F
    RNA; 2004 Mar; 10(3):438-47. PubMed ID: 14970389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective inhibition in animals of viral pathogenesis by a ribozyme derived from RNase P catalytic RNA.
    Bai Y; Trang P; Li H; Kim K; Zhou T; Liu F
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10919-24. PubMed ID: 18663226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of RNase P ribozyme for gene-targeting applications.
    Raj SM; Liu F
    Gene; 2003 Aug; 313():59-69. PubMed ID: 12957377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of an RNase P ribozyme against the mRNA encoding human cytomegalovirus protease inhibits viral capsid protein processing and growth.
    Trang P; Kim K; Zhu J; Liu F
    J Mol Biol; 2003 May; 328(5):1123-35. PubMed ID: 12729746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of gene expression in human cells using RNase P-derived ribozymes and external guide sequences.
    Kim K; Liu F
    Biochim Biophys Acta; 2007; 1769(11-12):603-12. PubMed ID: 17976837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins.
    Kim K; Trang P; Umamoto S; Hai R; Liu F
    Nucleic Acids Res; 2004; 32(11):3427-34. PubMed ID: 15220469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting mRNAs by engineered sequence-specific RNase P ribozymes.
    Bai Y; Sunkara N; Liu F
    Methods Mol Biol; 2012; 848():357-68. PubMed ID: 22315080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the regions of RNase P catalytic RNA that are potentially in close contact with its protein cofactor.
    Trang P; Liu F
    Methods Mol Biol; 2008; 488():267-77. PubMed ID: 18982298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro construction of effective M1GS ribozymes targeting HCMV UL54 RNA segments.
    Su YZ; Li HJ; Li YQ; Chen HJ; Tang DS; Zhang X; Jiang H; Zhou TH
    Acta Biochim Biophys Sin (Shanghai); 2005 Mar; 37(3):210-4. PubMed ID: 15756425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral delivery of RNase P ribozymes by Salmonella inhibits viral infection in mice.
    Bai Y; Gong H; Li H; Vu GP; Lu S; Liu F
    Proc Natl Acad Sci U S A; 2011 Feb; 108(8):3222-7. PubMed ID: 21300908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.